Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1389 of 5804
-
Could a common diabetes drug ease knee arthritis pain?
Symptom relief Recruiting nowKnee osteoarthritis (OA) is a chronic, painful disease associated with considerable morbidity, costs and disability. It is estimated that over a third of people aged over 60 have radiographic knee OA2 and over 50% of these with knee OA will go on to have a total knee replacement …
Phase: PHASE3 • Sponsor: Mostafa Bahaa • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New hope for rare appendix cancer: targeted chemotherapy delivered straight to the belly
Disease control Recruiting nowTo find the recommended dose of the drug paclitaxel that can be given intraperitoneally (given directly into the abdominal cavity) to participants with metastatic appendiceal adenocarcinoma.
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New drug combo aims to outsmart recurrent ovarian cancer
Disease control Recruiting nowThis is a clinical trial using CPI-0209 in combination with Carboplatin chemotherapy followed by CPI-0209 maintenance in patients with platinum sensitive, recurrent ovarian cancer.
Phase: PHASE1 • Sponsor: Lan Coffman • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Weekly MRI boosts radiation precision for brain cancer patients
Disease control OngoingThe purpose of this study is to find out if performing additional Magnetic Resonance Image (MRI) scans of the subjects' brain during each week of the radiation treatment of their high-grade glioma will help improve the radiation treatment.
Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New hope for HS sufferers: Long-Term drug safety trial underway
Disease control OngoingThe purpose of this study is to evaluate long-term safety and efficacy of povorcitinib in participants with moderate to severe hidradenitis suppurativa who completed the 54 weeks of study treatment within the originating parent Phase 3 studies (INCB 54707-301 \[NCT05620823\] or I…
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug cocktail aims to boost CAR T-Cell success in lymphoma
Disease control Recruiting nowThis phase I trial tests the safety, side effects and best dose of CC-99282 with rituximab for the treatment of patients who have received chimeric antigen receptor (CAR) T cell therapy for non-Hodgkins lymphoma and in whom have had a sub-optimal response early on to CAR T-cell t…
Phase: PHASE1 • Sponsor: Nathan Denlinger • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New hope for Tough-to-Treat colorectal cancer?
Disease control OngoingThis is an open-label clinical trial aimed at evaluating the safety and efficacy of the combination treatment of nelmastobart with capecitabine in patients diagnosed with metastatic or recurrent colorectal cancer.
Phase: PHASE1, PHASE2 • Sponsor: Korea University Anam Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:25 UTC
-
Interval training may help older veterans fight frailty
Symptom relief Recruiting nowFrailty is defined as a greater susceptibility to stressors resulting from age-related impairments in adaptive biological systems. Frailty leads to poorer physical performance and functional capacity and higher risk of adverse outcomes including falls, hospitalization, and mortal…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New IV fentanyl strategy aims to improve opioid addiction treatment
Disease control CompletedThe goal of this clinical trial is to test a treatment strategy for individuals with opioid use disorder (OUD) who use fentanyl. Participants will receive medically-administered doses of intravenous (IV) fentanyl at intervals until they are comfortable and do not have withdrawal …
Phase: PHASE4 • Sponsor: Pouya Azar • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New shot could stop chronic hives when antihistamines fail
Disease control CompletedThe study is a Phase II, multicenter, randomized, double-blind study to evaluatethe efficacy and safety of LP-003 administered subcutaneously as an add-on therapy for the treatment of adult patients aged 18-75 who have been diagnosed with refractory CSU and who remain symptomatic…
Phase: PHASE2 • Sponsor: Longbio Pharma • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Zapping anxiety: head device shows promise for young adults with GAD
Symptom relief CompletedThe purpose of this research study is to study cranial electrotherapy stimulation (CES) to determine its effects on symptoms of anxiety in people with generalized anxiety disorder (GAD) between the ages of 18 - 21 years of age.
Phase: NA • Sponsor: Electromedical Products International, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Texts and smart gadget aim to boost cancer pill adherence
Disease control Recruiting nowThis clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a medication monitoring device called WiseBag along with text message reminders for missed or extra medication events, to enhanced usual care (EUC), where patients …
Phase: NA • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a Fat-Blocking pill tame deadly high blood fats?
Disease control Recruiting nowType I hyperlipoproteinemia (T1HLP, also known as familial chylomicronemia syndrome or FCS) is a rare diseasewhere the blood triglycerides (fats) are very high. It is caused by lack of certain enzymes and proteins in the bodythat are important in disposing circulating fats from b…
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Sound waves aim to calm uncontrollable movements in kids with cerebral palsy
Symptom relief Recruiting nowThe primary objective of the proposed study is to evaluate the safety of ExAblate Transcranial MRgFUS as a tool for creating bilateral or unilateral lesions in the globus pallidus (GPi) in patients with treatment-refractory secondary dystonia due to dyskinetic cerebral palsy
Phase: NA • Sponsor: Children's National Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Massive study probes why black patients fare worse in advanced cancer
Knowledge-focused Recruiting nowThis is a non-randomized observational trial designed to collect detailed clinical, social determinant, and genomic data from patients enrolled in molecular oncology tumor boards across four comprehensive cancer centers.
Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Hope for Friedreich's ataxia: new drug trial aims to slow disease progression
Disease control Recruiting nowAn open label study designed to evaluate the safety, PK, PD, and clinical effects of long-term daily administration of CTI-1601 enrolling adolescent and adult patients with FRDA who have participated in a prior clinical study of CTI-1601 as well as children (age 2 years and older…
Phase: PHASE2 • Sponsor: Larimar Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New anemia drug for dialysis patients enters final testing phase
Disease control Recruiting nowAn investigator-blinded, randomized, multicenter, active-controlled Phase III study for the treatment of anemia in patients with CKD on hemodialysis
Phase: PHASE3 • Sponsor: Genexine, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New radiation approach aims to ease bone cancer pain
Symptom relief Recruiting nowTo compare increasing doses and different treatment schedules of stereotactic body radiation therapy (SBRT) against standard treatment scheduling.
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
New device may prevent muscle loss in ventilator patients
Disease control Recruiting nowThe study is a prospective, multi-center, randomized, controlled study using adaptive design to assess the evidence of safety and performance of the STIMIT Activator 1 System in the treatment of patients who have been mechanically ventilated for up to 7 days and are predicted to …
Phase: NA • Sponsor: Stimit AG • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New Parkinson's pump shows promise in Real-World test
Disease control OngoingParkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot from person to person. Some symptoms of PD are tremors, stiffness, and slowness of movement. The purpose of this study is to evaluate…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC